Correlation Between Shinhan Financial and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Shinhan Financial and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shinhan Financial and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shinhan Financial Group and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Shinhan Financial and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shinhan Financial with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shinhan Financial and Rapport Therapeutics,.
Diversification Opportunities for Shinhan Financial and Rapport Therapeutics,
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Shinhan and Rapport is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Shinhan Financial Group and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Shinhan Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shinhan Financial Group are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Shinhan Financial i.e., Shinhan Financial and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Shinhan Financial and Rapport Therapeutics,
Considering the 90-day investment horizon Shinhan Financial Group is expected to generate 0.57 times more return on investment than Rapport Therapeutics,. However, Shinhan Financial Group is 1.75 times less risky than Rapport Therapeutics,. It trades about -0.02 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.11 per unit of risk. If you would invest 3,141 in Shinhan Financial Group on January 11, 2025 and sell it today you would lose (68.00) from holding Shinhan Financial Group or give up 2.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Shinhan Financial Group vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Shinhan Financial |
| Rapport Therapeutics, |
Shinhan Financial and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Shinhan Financial and Rapport Therapeutics,
The main advantage of trading using opposite Shinhan Financial and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shinhan Financial position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Shinhan Financial vs. Community West Bancshares | Shinhan Financial vs. First Financial Northwest | Shinhan Financial vs. Ponce Financial Group | Shinhan Financial vs. Finwise Bancorp |
| Rapport Therapeutics, vs. One Gas | Rapport Therapeutics, vs. Skechers USA | Rapport Therapeutics, vs. American Electric Power | Rapport Therapeutics, vs. Lands End |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |